Posted a month ago

Company overview

Revolution Medicines, Inc. is a biotechnology company focused on developing targeted therapies for cancer treatment. They specialize in creating innovative drugs that inhibit critical pathways involved in cancer cell growth and survival, particularly targeting RAS and mTOR signaling pathways. The company generates revenue through the development and commercialization of its proprietary drug candidates, often collaborating with other pharmaceutical companies for research and development. Founded in 2014, Revolution Medicines has made significant strides in oncology, with several promising candidates in clinical trials, reflecting its commitment to transforming cancer treatment.